Gotham Therapeutics

Research, Research, Biotechnology research
Founded in 2017
New York, New York
http://www.gothamtx.com
None

About Gotham Therapeutics

Gotham Therapeutics has assembled an exceptional team and network to establish a novel drug class targeting RNA-modifying proteins. By changing the activity of proteins that modify messenger RNA, we aim to develop new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. We are applying a 360-degree approach to small molecule drug design to build a pipeline based on the promise of this rapidly emerging biopharmaceutical field.

Company Metrics

  • Employees: Unknown
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 54M None
  • Last Funding: 54M None (None)
  • Funding Status: None

Technology Stack

Gotham Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Research, Research, Biotechnology research

Headquarters: New York, New York